SRSF1, a splicing-factor oncoprotein: Prospective biomarker and therapeutic target for oral cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

SRSF1, a splicing-factor oncoprotein: Prospective biomarker and therapeutic target for oral cancer

Published:2024-12 Issue:6 Volume:125 Page:101800
ISSN:2468-7855
Container-title:Journal of Stomatology, Oral and Maxillofacial Surgery
language:en
Short-container-title:Journal of Stomatology, Oral and Maxillofacial Surgery

Author:

Thiruvengadam Rekha,Thiruvengadam Muthu^ORCID

Funder

Konkuk University

Publisher

Elsevier BV

Reference15 articles.

1. Nanotechnology, in silico and endocrine-based strategy for delivering paclitaxel and miRNA: prospects for the therapeutic management of breast cancer;Ansari;Semin Cancer Biol,2021

2. An alternative splicing network links cell-cycle control to apoptosis;Moore;Cell,2010

3. The gene encoding the splicing factor SF2/ASF is a proto-oncogene;Karni;Nat Struct Mol Biol,2007

4. The splicing-factor SRSF1 regulates apoptosis and proliferation to promote mammary epithelial cell transformation;Anczuków;Nat Struct Mol Biol,2012

5. Phosphorylation of the eukaryotic translation initiation factor eIF4E contributes to its transformation and mRNA transport activities;Topisirovic;Cancer Res,2004

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP